U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C20H26O5S
Molecular Weight 378.482
Optical Activity UNSPECIFIED
Defined Stereocenters 6 / 6
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NORETHINDRONE SULFATE

SMILES

[H][C@@]12CC[C@@](OS(O)(=O)=O)(C#C)[C@@]1(C)CC[C@]3([H])[C@@]4([H])CCC(=O)C=C4CC[C@@]23[H]

InChI

InChIKey=GCUIJBFFHDSMDP-XGXHKTLJSA-N
InChI=1S/C20H26O5S/c1-3-20(25-26(22,23)24)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,12,15-18H,4-11H2,2H3,(H,22,23,24)/t15-,16+,17+,18-,19-,20-/m0/s1

HIDE SMILES / InChI

Molecular Formula C20H26O5S
Molecular Weight 378.482
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 6 / 6
E/Z Centers 0
Optical Activity UNSPECIFIED

Norethindrone sulfate is a metabolite of the hormonal contraceptive drug, norethindrone.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Sat Dec 16 09:59:08 GMT 2023
Edited
by admin
on Sat Dec 16 09:59:08 GMT 2023
Record UNII
G2T31E947D
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NORETHINDRONE SULFATE
Common Name English
19-NOR-17.ALPHA.-PREGN-4-EN-20-YN-3-ONE, 17-HYDROXY-, HYDROGEN SULFATE
Common Name English
19-NORPREGN-4-EN-20-YN-3-ONE, 17-(SULFOOXY)-, (17.ALPHA.)-
Common Name English
Code System Code Type Description
FDA UNII
G2T31E947D
Created by admin on Sat Dec 16 09:59:09 GMT 2023 , Edited by admin on Sat Dec 16 09:59:09 GMT 2023
PRIMARY
EPA CompTox
DTXSID90676076
Created by admin on Sat Dec 16 09:59:09 GMT 2023 , Edited by admin on Sat Dec 16 09:59:09 GMT 2023
PRIMARY
CAS
19778-24-6
Created by admin on Sat Dec 16 09:59:09 GMT 2023 , Edited by admin on Sat Dec 16 09:59:09 GMT 2023
PRIMARY
PUBCHEM
29985972
Created by admin on Sat Dec 16 09:59:09 GMT 2023 , Edited by admin on Sat Dec 16 09:59:09 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> METABOLITE INACTIVE
Unit: ng/mL; 1mg (w/50mcg mestranol) q.d. oral administration sampled on the 7th, 14th, and 21st days (two females)
IN-VIVO
PLASMA